Stay updated on Treprostinil Inhalation Powder in PAH Clinical Trial
Sign up to get notified when there's something new on the Treprostinil Inhalation Powder in PAH Clinical Trial page.

Latest updates to the Treprostinil Inhalation Powder in PAH Clinical Trial page
- Check4 days agoChange DetectedThe page’s displayed maintenance/release revision indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check11 days agoChange DetectedA new revision tag 'Revision: v3.5.2' was added to the history, replacing the previous 'Revision: v3.5.0'.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new Study Status entry was added in the history on 2026-03-30, and an entry dated 2025-04-10 was deleted.SummaryDifference0.3%

- Check40 days agoChange DetectedThe history now includes a new revision, v3.5.0, and the older revision v3.4.3 was removed from the history.SummaryDifference0.1%

- Check47 days agoChange DetectedThe history now shows a new revision v3.4.3 and removes the previous v3.4.2.SummaryDifference0.1%

- Check75 days agoChange DetectedA new Revision: v3.4.2 was added to the history; Revision: v3.4.1 and the government funding notice were removed.SummaryDifference0.5%

Stay in the know with updates to Treprostinil Inhalation Powder in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Treprostinil Inhalation Powder in PAH Clinical Trial page.